Coverage
-
September 05, 2013
Warner Chilcott PLC and Mayne Pharma International Pty. Ltd. have agreed to pay $12 million to Mylan Inc. and Mylan Pharmaceuticals Inc. to resolve Mylan's damages claim following patent litigation over Warner's acne drug Doryx, according to a regulatory notice filed Wednesday.
2 other articles on this case.
View all »